Big Pharma Responsible For More Deaths Than Illegal Drug Trade


According to the CDC, prescription medications put consumers at a much greater risk than illegal drugs. They estimate the death toll related to pharmaceutical drugs at 23,000 for the year 2013 alone. That puts prescription drugs such as oxycontin and tricyclic antidepressants at a much higher likelihood for causing death than drugs commonly seen as ‘killers’ such as heroin and cocaine.

So why are these prescription drugs not illegal? Well, thanks to massive advertising campaigns and the availability of information regarding the benefits but not the risks, many people don’t see prescription medications as quite on the same page as illicit substances.

And then there’s the honest fact that there is far much more money and power involved in funding drug wars while shoving toxic poison with minimal benefits down the throats of everyone from teenagers to senior citizens.

How can we solve this issue? The same CDC report that broke the statistics suggests that campaigns must be put together that inform both adults and children about the risks associated with prescription drugs and the likelihood of abuse, which stands much higher than many people believe.

But it’ll be hard to make that happen while our government is still fully supporting the interests of large pharmaceutical companies around the world and launching misleading campaigns against a drug trade who’s products kill less people than their so-called cures.



Mammograms may not reduce breast cancer deaths

Breast cancer screenings may not lead to fewer deaths but may lead to overdiagnosis, U.S. researchers suggest.

In areas of the US with high levels of screening, more tumors were diagnosed – but breast cancer death rates were no lower than in areas with fewer screenings, researchers report.

“The most dramatic finding of our study is the immediately evident – and substantial – evidence of breast cancer overdiagnosis,” he told Reuters Health in an email.

Each year, about 230,000 US women are newly diagnosed with breast cancer, according to the National Cancer Institute.

While screening guidelines vary, the government-backed US Preventive Services Task Force says average-risk women should have.